MG-O-1002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MG-O-1002, covering 2024-03-13 to 2024-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Effect on Central Macular Thickness of Treatment With MG-O-1002 Eye Drops in Participants Aged Over 45 With Neovascular Age-related Macular Degeneration (nAMD) [Phase 2]